Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2012HepatologyOpen Access

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

TATokuzo AraoKindai UniversityKUKazuomi UeshimaKindai University Sakai HospitalKMKazuko MatsumotoKanazawa University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Arao et al. (2012) studied this question.

synapsesocial.com/papers/6a6d0d088031ec7bb1db51ffhttps://doi.org/10.1002/hep.25956
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma2007 · 485 citations
  2. 2BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis2004 · 4,058 citations
  3. 3Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa.1986 · 274 citations
  4. 4Recurrence of hepatocellular carcinoma after surgery1996 · 297 citations